Company Filing History:
1 out of 1,092 
1 out of 832,891 Years Active: 2022
Title: Shiqiang Shang: Innovator in Electromagnetic Field Applications for Tumor Treatment
Introduction
Shiqiang Shang is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of medical technology, particularly in the treatment of pathological cells. His innovative approach focuses on utilizing electromagnetic fields to suppress tumors, showcasing his commitment to advancing healthcare solutions.
Latest Patents
Shang holds a patent for an "Apparatus for treating pathological cells." This electromagnetic field generating apparatus is designed specifically for tumor suppression. The invention operates with a ratio of static magnetic field to alternating magnetic field ranging from 0.5 to 2.5, with a total intensity of up to 100 mT. It offers a non-invasive treatment option with low toxicity and minimal side effects, effectively inhibiting multiple tumors. The mechanism of action involves influencing intracellular superoxide radical content and promoting cell autophagy. Additionally, the apparatus can utilize an additional magnetic field with frequencies up to 100 MHz and intensities down to the microTesla range to enhance antitumor efficacy.
Career Highlights
Shiqiang Shang has worked at Zhejiang University, where he has likely collaborated with other researchers and contributed to various projects in the field of medical technology. His work emphasizes the importance of innovative solutions in treating complex health issues.
Collaborations
Shang has collaborated with notable individuals such as Santi Tofani and Xi Chen. These partnerships have likely enriched his research and development efforts, leading to advancements in his field.
Conclusion
Shiqiang Shang's contributions to the development of electromagnetic field applications for tumor treatment highlight his innovative spirit and dedication to improving healthcare. His patent reflects a significant step forward in non-invasive medical treatments, showcasing the potential of technology in addressing critical health challenges.